Suppr超能文献

实体瘤中肿瘤起始细胞的常见标志物带来的启示。

Lessons from common markers of tumor-initiating cells in solid cancers.

机构信息

Department of Otorhinolaryngology, Head and Neck Surgery, Grosshadern Medical Center, Ludwig-Maximilians-University of Munich, Marchioninistr. 15, 81377 Munich, Germany.

出版信息

Cell Mol Life Sci. 2011 Dec;68(24):4009-22. doi: 10.1007/s00018-011-0772-9. Epub 2011 Jul 24.

Abstract

Tumor-initiating cells (TICs) have emerged as the driving force of carcinomas, which appear as hierarchically structured. TICs as opposed to the tumor bulk display tumor forming potential, which is linked to a certain degree of self-renewal and differentiation, both major features of stem cells. Markers such as CD44, CD133, CD24, EpCAM, CD166, Lgr5, CD47, and ALDH have been described, which allow for the prospective enrichment of TICs. It is conspicuous that the same markers allow for an enrichment of TICs in various entities and, on the other hand, that different combinations of these markers were independently reported for the same tumor entity. Potential functions of these markers in the regulation of TIC phenotypes remained somewhat neglected although they might give insights in common molecular themes of TICs. The present review discusses major TIC markers with respect to their function and potential contributions to the tumorigenic phenotype of TICs.

摘要

肿瘤起始细胞(TICs)已成为癌的驱动因素,这些细胞表现出层次结构。与肿瘤大部分不同,TICs 具有肿瘤形成潜力,这与一定程度的自我更新和分化有关,而自我更新和分化是干细胞的主要特征。已经描述了诸如 CD44、CD133、CD24、EpCAM、CD166、Lgr5、CD47 和 ALDH 等标记物,这些标记物允许 TICs 的前瞻性富集。值得注意的是,相同的标记物允许在各种实体中富集 TICs,另一方面,不同组合的这些标记物被独立地报告用于相同的肿瘤实体。尽管这些标记物可能为 TIC 的共同分子主题提供了一些见解,但它们在调节 TIC 表型中的潜在功能仍有些被忽视。本文综述了主要的 TIC 标记物,讨论了它们的功能及其对 TIC 肿瘤发生表型的潜在贡献。

相似文献

1
Lessons from common markers of tumor-initiating cells in solid cancers.
Cell Mol Life Sci. 2011 Dec;68(24):4009-22. doi: 10.1007/s00018-011-0772-9. Epub 2011 Jul 24.
2
Effect of EpCAM, CD44, CD133 and CD166 expression on patient survival in tumours of the ampulla of Vater.
J Clin Pathol. 2012 Feb;65(2):140-5. doi: 10.1136/jclinpath-2011-200043. Epub 2011 Nov 30.
4
Colon cancer stem cells: implications in carcinogenesis.
Front Biosci (Landmark Ed). 2011 Jan 1;16(5):1651-62. doi: 10.2741/3811.
6
Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer.
Oncol Rep. 2012 Oct;28(4):1301-8. doi: 10.3892/or.2012.1951. Epub 2012 Aug 6.

引用本文的文献

1
2
LncRNA PCAT6 is a predictor of poor prognosis of colorectal cancer.
J Gastrointest Oncol. 2024 Feb 29;15(1):190-202. doi: 10.21037/jgo-23-910. Epub 2024 Feb 28.
3
MiR-942-3p as a Potential Prognostic Marker of Gastric Cancer Associated with AR and MAPK/ERK Signaling Pathway.
Curr Issues Mol Biol. 2022 Aug 24;44(9):3835-3848. doi: 10.3390/cimb44090263.
5
The critical role of peroxiredoxin-2 in colon cancer stem cells.
Aging (Albany NY). 2021 Mar 26;13(8):11170-11187. doi: 10.18632/aging.202784.
7
Abnormal expression of ABCD3 is an independent prognostic factor for colorectal cancer.
Oncol Lett. 2020 May;19(5):3567-3577. doi: 10.3892/ol.2020.11463. Epub 2020 Mar 16.
8
A Five-microRNA Signature as Prognostic Biomarker in Colorectal Cancer by Bioinformatics Analysis.
Front Oncol. 2019 Nov 12;9:1207. doi: 10.3389/fonc.2019.01207. eCollection 2019.
9
Rationales for the Use of Cancer Stem Cells Markers in the Staging of Papillary Thyroid Carcinoma.
J Oncol. 2019 Jun 24;2019:1659654. doi: 10.1155/2019/1659654. eCollection 2019.
10
LncRNA MIR4435-2HG predicts poor prognosis in patients with colorectal cancer.
PeerJ. 2019 Apr 2;7:e6683. doi: 10.7717/peerj.6683. eCollection 2019.

本文引用的文献

1
CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?
Nat Rev Cancer. 2011 Apr;11(4):254-67. doi: 10.1038/nrc3023. Epub 2011 Mar 10.
4
CD133 negative cancer stem cells in glioblastoma.
Front Biosci (Elite Ed). 2011 Jan 1;3(2):701-10. doi: 10.2741/e280.
6
Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties.
PLoS One. 2010 Nov 19;5(11):e14062. doi: 10.1371/journal.pone.0014062.
7
The role of human aldehyde dehydrogenase in normal and cancer stem cells.
Stem Cell Rev Rep. 2011 Jun;7(2):292-306. doi: 10.1007/s12015-010-9208-4.
8
ALCAM/CD166: cancer-related issues.
Cancer Genomics Proteomics. 2010 Sep-Oct;7(5):231-43.
9
CD44+ CD133+ population exhibits cancer stem cell-like characteristics in human gallbladder carcinoma.
Cancer Biol Ther. 2010 Dec 1;10(11):1182-90. doi: 10.4161/cbt.10.11.13664.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验